Opium addiction increases interleukin 1 receptor antagonist (IL-1Ra) in the coronary artery disease patients

PLoS One. 2012;7(9):e44939. doi: 10.1371/journal.pone.0044939. Epub 2012 Sep 19.

Abstract

Background: There is evidence that opium addiction has immunosuppressant effects. Coronary artery disease (CAD) is a condition resulted from atherosclerosis which is dependent on the immune response.

Purpose: To evaluate plasma levels of interleukin-6 and interleukin-1Ra in 30 patients with three-vessel coronary artery disease, ejection fraction of more than 35% and to evaluate their changes after prognostic treadmill test in 15 opium addicted and 15 non-addicted patients.

Methods: The participants underwent prognostic treadmill test and plasma levels of interleukin-6 (IL-6) and interleukin-1Ra (IL-1Ra) were evaluated with ELISA method before, just after and 4 hours after the test.

Results: IL-1Ra (2183 pg/ml) tended to decrease over time in the opium addicted group (1372 pg/ml after prognostic treadmill test and 1034 pg/ml 4 hours after that), although such decrease did not reach the statistical significance. IL-1Ra levels were significantly higher in opium addicted than in non addicted patients. Opium addiction had no significant effect on IL-6 changes.

Conclusion: Consumption of opium in CAD patients is associated with higher IL-1Ra levels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Case-Control Studies
  • Coronary Artery Disease / complications*
  • Exercise Test
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / blood*
  • Interleukin-6 / blood
  • Male
  • Opioid-Related Disorders / blood*
  • Opioid-Related Disorders / complications*
  • Opioid-Related Disorders / diagnosis
  • Opioid-Related Disorders / physiopathology
  • Opium / pharmacology*
  • Prognosis
  • Stroke Volume / drug effects

Substances

  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-6
  • Opium

Grants and funding

This study has been supported by a grant from the Shahid Beheshti University of Medical Sciences (SBMU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.